secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2026-06-10T20:05:35+00:00
Accession:  0001104659-26-072324
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Voyager shareholders approve doubling authorized shares to 245M
---------------------------------------------------------------

- Authorized capital stock increased from 125M to 245M; common stock from 120M to 240M, effective June 9, 2026.
- Shareholders elected James Geraghty, Steven Hyman, and Alfred Sandrock as Class II directors until 2029.
- Ratified Ernst & Young as independent auditor for fiscal year ending December 31, 2026.
- Advisory vote on executive compensation approved with 32M for, 910K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465926072324/0001104659-26-072324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465926072324/tm2617230d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-072324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer